Patents by Inventor Paul McGee

Paul McGee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS AND SALTS OF A MUSCARINIC RECEPTOR AGONIST
    Publication number: 20250340531
    Abstract: This invention relates to compounds and salts thereof that are muscarinic receptor agonists and which are useful in the treatment of muscarinic receptor mediated diseases. Also provided are crystalline forms of the compounds and salts thereof; pharmaceutical compositions containing the compounds and salts thereof, or crystalline forms thereof; therapeutic uses of the compounds and salts thereof, or crystalline forms thereof; methods of synthesis thereof; and intermediates useful in said methods of synthesis.
    Type: Application
    Filed: August 3, 2023
    Publication date: November 6, 2025
    Inventors: Giles Albert Brown, Paul McGee, Julie Cansfield, Mark Pickworth
  • Polymorph forms of desazadesferrithiocin analogs
    Patent number: 9512095
    Abstract: The present invention provides a solid form and compositions thereof, which are useful as metal chelators and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: December 6, 2016
    Assignee: FERROKIN BIOSCIENCES, INC.
    Inventors: Srini Tenjarla, Paul McGee
  • POLYMORPH FORMS OF DESAZADESFERRITHIOCIN ANALOGS
    Publication number: 20160024034
    Abstract: The present invention provides a solid form and compositions thereof, which are useful as metal chelators and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Srini Tenjarla, Paul McGee
  • Process for the preparation of anagrelide and analogues thereof
    Patent number: 9067944
    Abstract: The present invention relates to a novel process for producing anagrelide, 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin 2(3H)-one, or certain analogs thereof. The process of the invention also provides improved processes for producing key intermediates required for the synthesis of anagrelide or certain analogs thereof.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: June 30, 2015
    Assignee: SHIRE LLC
    Inventor: Paul McGee
  • PROCESS FOR THE PREPARATION OF ANAGRELIDE AND ANALOGUES THEREOF
    Publication number: 20130211083
    Abstract: The present invention relates to a novel process for producing anagrelide, 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin 2(3H)-one, or certain analogues thereof. The process of the invention also provides improved processes for producing key intermediates required for the synthesis of anagrelide or certain analogues thereof.
    Type: Application
    Filed: October 21, 2011
    Publication date: August 15, 2013
    Applicant: SHIRE LLC
    Inventor: Paul McGee
  • MEPTAZINOL CARBAMATE PRODRUG SALTS
    Publication number: 20120165315
    Abstract: The present invention relates to salts of meptazinol carbamate prodrugs, and to their synthesis and use.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 28, 2012
    Inventors: Paul McGee, R. Melling, Jean-Luc Coudret, A. Manage, Jean-Francois Camiaux, Colin Lindley
  • PROCESS FOR THE SYNTHESIS OF PRODRUGS OF OPIOIDS
    Publication number: 20120165520
    Abstract: The present invention provides a process for the synthesis of opioid prodrugs. In particular, the present invention provides a process for the synthesis of opioid prodrugs comprising: treating an opioid, in the form of a salt or a freebase, with a carbonyl synthon to form an activated intermediate and subsequently reacting the activated intermediate with an amine, in the form of a salt or a freebase.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 28, 2012
    Inventors: Paul McGee, Ian Garnett, E. Juan, A. Manage, Jean-Francois Carniaux